health Diagnostic Laboratory, Inc., a privately held life sciences company, Saturday said it formed a strategic alliance with Global Genomics Group or G3 to detect human susceptibility to cardiovascular disease through the discovery of genetic biomarkers.
G3 and HDL will create a new scientific process that uses advanced imaging to measure biological information.
Voros, G3’s CEO and co-founder, said, “We focus our research around how human genetic variation affects heart disease risk. Our solution is to tie the use of advanced imaging to genetics and genomics—which will lead to more telling and innovative discoveries for the cardiovascular therapeutic market.”
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News